Pembrolizumab,Vibostolimab,Gebasaxturev,MK-4830,Favezelimab,trametinib,PDR001,dabrafenib
Merck,Novartis
['biomarker', 'melanoma']
happening soon at #aacr23: reinhard dummer takes the stage to report on keymaker-u02 substudy 02c for stage iiib-d melanoma. take a look at phase 3 (combi -i) research from et al on the potential in biomarkers in braf v600-mutant melanoma: #jitc 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)